Tian Zhang: Updates on PDIGREE adaptive phase III of ipi/nivo/cabo at DAVA Oncology GU Summit24
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, reshared a post by Qian Janie Qin, Assistant Professor at UT Southwestern, on X, adding:
“Was a privilege to discuss our journey with PDIGREE in kidney cancer this morning, a lesson for the long term perseverance of all our investigators in Alliance for Clinical Trials in Oncology and across NCI CTEP Clinical Research NCTN groups!
Thanks DAVA Oncology!”
Quoting Qian Janie Qin‘s post:
“Dr. Tian Zhang giving updates on PDIGREE adaptive phase III of ipi/nivo/cabo DAVA Oncology GUSUMMIT24, completed accrual, stay tuned!”
For more Updates, Follow OncoDaily.
Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma. She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee. She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023